Skip to content
Screener

Cumberland Pharmaceuticals CPIX Assets Held for Sale

Assets Held for Sale at other companies

Organon logo
OrganonOGN
$0
Cardinal Health logo
Cardinal HealthCAH
$0-100%

Other financials

Income statement

See full
Revenue$166.5K-56.3%
Gross profit$7.2M-30.0%
Operating income-$3.2M-1.3%
Net income-$4.3M-477%
EPS (diluted)-$0.29-480%

Balance sheet

See full
Cash & equivalents$3.9M-76.0%
Total debt$4.7M-7.6%
Total equity$17.4M-37.7%
Total assets$62.9M-7.4%

Cash flow

See full
Operating cash flow$168.7K-80.0%
CapEx$38.3K+44.5%
Free cash flow$130.5K-84.0%

Valuation

See full
Market cap$115.07M+140%
Enterprise value$115.92M+213%
P/S3.7×+2.2×

Profitability

See full
Gross margin77.2%-7.1pp
Operating margin-30.8%+135pp
Net margin-34.9%-54.7pp
FCF margin2.2%

Returns & leverage

See full
Return on equity-48.1%-67.6pp
Debt / equity0.3×+0.1×
Current ratio-0.3×

Where this comes from

Reported directly by Cumberland Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent.

The source filing: Cumberland Pharmaceuticals’s 10-Q, filed August 7, 2026. Open the filing →

Filed
Aug 7, 2026, 5:12 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001087294-26-000062

FAQ

What is Cumberland Pharmaceuticals's assets held for sale?
Cumberland Pharmaceuticals (CPIX) reported assets held for sale of $15.65M in Q2 2026.
What does assets held for sale mean?
Assets committed to a plan of sale, expected to be sold within one year, and carried at the lower of carrying amount or fair value less costs to sell.

Ask your AI about Cumberland Pharmaceuticals's assets held for sale.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude